Vertex Pharmaceuticals

Vertex shrugs off Q1 miss with ‘strong’ Journavx launch, encouraging pipeline position
BioSpace
Wed, 05/7/25 - 11:27 am
Vertex Pharmaceuticals
earnings
Journavx
Vertex pauses Moderna-partnered cystic fibrosis trial, takes $379M hit tied to separate program
Fierce Biotech
Tue, 05/6/25 - 09:38 pm
Vertex Pharmaceuticals
Moderna Therapeutics
cystic fibrosis
clinical trials
Vertex touts early uptake of Journavx, plots $1B+ sales trajectory for Casgevy
First Word Pharma
Mon, 05/5/25 - 11:02 pm
Vertex Pharmaceuticals
Journavx
Casgevy
Vertex discontinues AAV research for gene therapies
Fierce Biotech
Sun, 05/4/25 - 12:06 pm
Vertex Pharmaceuticals
AAV gene therapy
gene therapy
Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday
Motley Fool
Tue, 04/22/25 - 07:42 pm
Vertex Pharmaceuticals
Vertex CEO Reshma Kewalramani gets 4% pay bump to $21.5M
Fierce Pharma
Wed, 04/9/25 - 11:12 am
Vertex Pharmaceuticals
Reshma Kewalramani
excecutive compensation
Vertex halts development of diabetes cell therapy after trial failure
Clinical Trials Arena
Mon, 03/31/25 - 10:51 am
Vertex Pharmaceuticals
VX-264
type 1 diabetes
cell therapy
clinical trials
Latigo raises $150m for non-opioid painkiller push
Pharmaphorum
Mon, 03/17/25 - 10:06 am
Latigo
funding
non-opioid pain treatments
Vertex Pharmaceuticals
Journavx
Vertex’s new pain drug gets first coverage nod from major insurer
BioPharma Dive
Thu, 03/6/25 - 10:12 pm
Vertex Pharmaceuticals
PBMs
Unitedhealth Group
Journavx
Vertex axes Verve gene editing pact amid shift in R&D priorities
Fierce Biotech
Thu, 02/27/25 - 10:13 am
Vertex Pharmaceuticals
Verve Therapeutics
R&D
gene editing
Vertex COO Arbuckle to step down later this year
BioPharma Dive
Mon, 02/10/25 - 10:17 pm
Vertex Pharmaceuticals
Pharma COOs
Stuart Arbuckle
Charlie Wagner
Vertex's Revenue Surges but EPS Slips
Motley Fool
Mon, 02/10/25 - 10:13 pm
Vertex Pharmaceuticals
earnings
Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research
BioPharma Dive
Thu, 01/30/25 - 11:36 pm
Vertex Pharmaceuticals
non-opioid pain treatments
FDA
Journavx
A long-awaited alternative to opioids is on the FDA doorstep. Can Vertex seal the deal?
Pharma Voice
Wed, 01/29/25 - 11:15 am
Vertex Pharmaceuticals
non-opioid pain treatments
suzetrigine
Vertex pays Orna $65M to work on next-gen gene therapies for blood disorders
Fierce Biotech
Tue, 01/7/25 - 10:28 am
Vertex Pharmaceuticals
Orna Therapeutics
ReNAgade Therapeutics
gene therapy
sickle cell disease
transfusion-dependent beta thalassemia
5 FDA decisions to watch in the first quarter of 2025
BioPharma Dive
Mon, 01/6/25 - 06:54 pm
FDA
Vertex Pharmaceuticals
non-opioid pain treatments
suzetrigine
GSK
vaccines
MenABCWY
meningitis
Alnylam
vutrisiran
transthyretin amyloid cardiomyopathy
Soleno
diazoxide choline
Prader Willi syndrome
Sanofi
hemophilia
fitusiran
FDA approves drugs from Vertex, Novo, Bristol Myers to wrap 2024
BioPharma Dive
Thu, 01/2/25 - 11:35 am
FDA
Vertex Pharmaceuticals
Novo Nordisk
Bristol Myers Squibb
Alyftrek
cystic fibrosis
Alhemo
hemophilia
Opdivo Qvantiq
solid tumors
Vertex's pain trial hits endpoint but sinks stock as placebo comparison spooks investors
Fierce Biotech
Thu, 12/19/24 - 10:22 am
Vertex Pharmaceuticals
suzetrigine
painkillers
non-opioid pain treatments
ICER finds Vertex's non-opioid pain drug 'slightly' cost-saving, with fewer addiction risks
First Word Pharma
Mon, 12/9/24 - 08:58 pm
Vertex Pharmaceuticals
VX-548
ICER
non-opioid pain treatments
Gene therapy uptake in sickle cell stays slow, despite patient interest
BioPharma Dive
Mon, 12/9/24 - 10:37 am
gene therapy
sickle cell disease
patients
Casgevy
Lyfgenia
Bluebird Bio
Vertex Pharmaceuticals

Pages